NeuroBo Pharmaceuticals names new SVP, Operations
9 May 2022 -

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, announced on Friday that it has named Matthew Bardin, PharmD, BCPS as its senior vice president, Operations.

Dr Bardin is to report directly to president and chief executive officer, Gil Price, MD.

In the new role, Dr Bardin will be responsible for day to day operations, with a focus on clinical development.

Dr Bardin has held roles of increasing responsibility at Romark, LC, where he most recently served as vice president, Medical Affairs/Research and Development. He has worked at Clinical Pharmacology Services, Inc./Conexus Health last holding the position of Clinical Services manager. He has served as a Pharmacy Clinical Coordinator at South Florida Baptist Hospital and was a Pharmacy Practice Resident at Piedmont Hospital, in Atlanta, Georgia.